1. Safety of AS04‐HPV‐16/18 vaccine in Chinese women aged 26 years and older and long‐term protective effect in women vaccinated at age 18–25 years: A 10‐year follow‐up study
   Fanghui Zhao et al, 2023, Asia-Pacific Journal of Clinical Oncology CrossRef
2. The prevalence of human papillomavirus among women in northern Guangdong Province of China
   Wenbo Huang et al, 2022, Scientific Reports CrossRef
3. Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018–2020
   Qianhui Wu et al, 2023, Human Vaccines & Immunotherapeutics CrossRef
4. Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia
   Chichao Xia et al, 2021, Cancers CrossRef
5. Prevalence of Candida albicans in High-Risk Human Papillomavirus-Positive Women: A Study in Diyarbakır Province, Turkey
   Efdal Oktay Gultekin et al, 2023, Canadian Journal of Infectious Diseases and Medical Microbiology CrossRef
6. Prevalence and genotype distribution of HPV infection among women in Xiamen, China
   Ye Shen et al, 2023, Frontiers in Microbiology CrossRef